Airway responsiveness predicts lung function decline differently in subjects with or without asthma: An international study Source: Annual Congress 2013 –Risk factors for COPD and lung function decline Year: 2013
Serum heat shock protein levels in patients with chronic obstructive pulmonary disease Source: International Congress 2014 – Clinical problems in acute and chronic lung diseases Year: 2014
Lung function decline in COPD in relation to MMP-12 and surfactant protein A Source: International Congress 2016 – New signalling pathways in COPD Year: 2016
Osteopontin levels in sputum supernatant and serum of patients with lung cancer: Does coexistent COPD make the difference? Source: Annual Congress 2013 –Monitoring respiratory diseases: role of comorbidities and lung involvement Year: 2013
Correlation between extracellular heat shock protein 72 and clinical parameters including exhaled oxygen level in COPD Source: International Congress 2015 – Notable abstracts in exacerbations, mechanisms and biomarkers in COPD Year: 2015
Serum heat shock protein 47 levels in patients with drug induced lung diseases Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease Year: 2013
Relationship between plasma amino acid levels and lung function decline in patients with COPD Source: Annual Congress 2013 –COPD: markers and inflammation Year: 2013
Lung clearance index is increased in patients with COPD Source: International Congress 2015 – Monitoring and phenotyping COPD Year: 2015
Distribution of blood eosinophil in COPD patients Source: International Congress 2014 – Lung function, COPD and inflammation Year: 2014
Lung clearance index in alpha-1-antitrypsin deficiency - A follow up Source: International Congress 2016 – Functional assessment of the airways Year: 2016
COPD and lung cancer: Prevalence, infradiagnosis, phenotypes and multidimensional characterization Source: International Congress 2016 – Epidemiology and specific subgroups in lung cancer Year: 2016
Combined effects of lung function, blood gases and kidney function on the exacerbation risk in stable COPD: Results from the German COSYCONET cohort. Source: International Congress 2019 – Lung function evaluation and prognosis of airway diseases Year: 2019
Respiratory function and the risk of lung cancer in COPD patients: A population-based cohort study Source: International Congress 2016 – Epidemiology and specific subgroups in lung cancer Year: 2016
Alterations of the soluble proteome of airway epithelial cells in COPD Source: Annual Congress 2013 –New strategies in epigenomic research to study lung diseases (DNA rearrangements, RNA, methylation, proteosome) Year: 2013
Increased expression of a proliferation-inducing ligand (APRIL) in lung leukocytes and alveolar epithelial cells in COPD patients with non small cell lung cancer: A possible link between COPD and lung cancer? Source: International Congress 2016 – Mechanisms of disease Year: 2016
Airflow limitation, lung volumes and systemic inflammation in a general population Source: Eur Respir J 2011; 39: 29-37 Year: 2012
Airflow limitation, lung volumes and systemic inflammation in a general population Source: Eur Respir J 2012; 39: 29-37 Year: 2012
Simultaneously increased serum periostin and urinary EDN relates to reduced lung function in adults with asthma from the Swedish GA2LEN study Source: International Congress 2016 – Inflammatory biomarkers in airway diseases Year: 2016
The influence of hyperinflation on body composition and cytokine profile in patients with COPD Source: Annual Congress 2013 –Monitoring lung function in airway diseases Year: 2013
LATE-BREAKING ABSTRACT: Predictors of lung function decline in a cohort of subjects with severe asthma Source: International Congress 2015 – Monitoring airway diseases with lung function tests Year: 2015